Clearing and removing blood stasis decoction of the treatment of chronic prostatitis clinical observation
Tan Wei
Abstract
Tan Wei
Abstract
Objective :To observe the clearing and removing blood stasis decoction of the treatment of chronic prostatitis the clinical efficacy. Methods: 98 cases were divided into two groups, the treatment group of 56 cases, 42 cases of the control group. Treatment group is based on clearing an removing blood stasis decoction, modification according to symptoms, contrast with the use of levofloxacin and the Prostate health of the control group. Results: The treatment group and control group, the total efficiency were 91%, 71%, the treatment group is better cure rate than the control group. Conclusion: There is good effect of the clearing and removing blood stasis decoction of the trentment of chronic prostatitis , it is worth using.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective :To observe the clearing and removing blood stasis decoction of the treatment of chronic prostatitis the clinical efficacy. Methods: 98 cases were divided into two groups, the treatment group of 56 cases, 42 cases of the control group. Treatment group is based on clearing an removing blood stasis decoction, modification according to symptoms, contrast with the use of levofloxacin and the Prostate health of the control group. Results: The treatment group and control group, the total efficiency were 91%, 71%, the treatment group is better cure rate than the control group. Conclusion: There is good effect of the clearing and removing blood stasis decoction of the trentment of chronic prostatitis , it is worth using.
Key concepts: Medicine, Decoction, Prostatitis, Blood stasis, Levofloxacin, Clinical efficacy, Internal medicine, Treatment and control groups